Background illustration for clinical trials search

Paid Clinical Trials Bethesda

Discover 2,413 paid clinical trials in Bethesda, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin

for
Coronary Artery Disease
Location: Baltimore MD
Sponsor: LifeBridge Health

Sex: All

Age: 18+

Code: NCT00370045

Recruiting

White Matter Plasticity in Schizophrenia

for
Schizophrenia Disorders
Location: Catonsville MD
Sponsor: University of Maryland, Baltimore

Sex: All

Age: 15 - 45

Code: NCT06641297

Recruiting

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

for
Post-ERCP Acute Pancreatitis
Location: Baltimore MD
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT05252754

Phase3, Recruiting

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Baltimore MD, New York NY, Hackensack NJ, Toronto,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT05372354

Phase1, Phase2, Recruiting

Tempus Small Cell Lung Cancer Observational Study (Sculptor)

for
Small Cell Lung Cancer
Location: Baltimore MD, York PA, Chapel Hill NC, Columbus OH,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05257551

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Bowie MD, Baltimore MD, Richmond VA, Philadelphia PA,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)

for
Myelodysplastic Syndromes, Cytopenia
Location: Bethesda MD, Hackensack NJ, Shirley NY, Memphis TN,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT04419649

Phase2, Recruiting

Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis

for
Homeostatic Iron Regulator Gene-related Hereditary Hemochromatosis,
Location: Bethesda MD, Frederick MD, Durham NC, Chapel Hill NC,
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07332091

Phase2, Recruiting

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

for
Breast Cancer
Location: Bethesda MD, Silver Spring MD, Glen Burnie MD,
Sponsor: Exact Sciences Corporation

Sex: All

Age: 18+

Code: NCT06401421

Recruiting

Safety of Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage

for
Intraventricular Hemorrhage of Prematurity
Location: Baltimore MD, St. Petersburg FL
Sponsor: Johns Hopkins University

Sex: All

Age: 0

Code: NCT05617833

Phase1, Recruiting

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

for
Acne
Location: Rockville MD, Camp Hill PA, Lynchburg VA, Wilmington NC,
Sponsor: Sanofi Pasteur, a Sanofi Company

Sex: All

Age: 18 - 45

Code: NCT06316297

Phase1, Phase2, Recruiting

Carmustine Wafer in Combination With Retifanlimab and Radiation With/Without Temozolomide in Subjects With Glioblastoma

for
Glioblastoma Multiforme
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18 - 70+

Code: NCT05083754

Phase1, Recruiting

A Study of AK117 in Combination With Azacitidine in Patients With Myelodysplastic Syndromes

for
Higher-risk Myelodysplastic Syndromes
Location: Bethesda MD, Columbia MD, Bronx NY, Chapel Hill NC,
Sponsor: Akeso

Sex: All

Age: 18+

Code: NCT06196203

Phase2, Recruiting
New

Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies

for
Secondary Immune Deficiency
Location: Bethesda MD, Coral Springs FL
Sponsor: CSL Behring

Sex: All

Age: 18+

Code: NCT07648264

Phase3, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC

for
Non-squamous Non-small Cell Lung Cancer
Location: Fairfax VA, Baltimore MD, York PA, Newark DE, Camden NJ,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06627647

Phase3, Recruiting

Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea

for
Obesity, Diabetes, Obstructive Sleep Apnea
Location: Bethesda MD
Sponsor: Mid-Atlantic Epilepsy and Sleep Center, LLC

Sex: All

Age: 18 - 70

Code: NCT02069197

Phase2, Recruiting

ATLAS (AltaValve) Pivotal Trial

for
Mitral Regurgitation, Mitral Insufficiency,
Location: Baltimore MD, Columbia MD, Charlottesville VA,
Sponsor: 4C Medical Technologies, Inc.

Sex: All

Age: 18+

Code: NCT06465745

Recruiting

A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation

for
Lung Transplant
Location: Baltimore MD, Philadelphia PA, Columbus OH,
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT05547698

Recruiting

Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial

for
Glaucoma
Location: Baltimore MD, Chapel Hill NC, Buffalo NY, Toronto,
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT05924477

Recruiting

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Washington D.C. DC, Glen Burnie MD, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06058377

Phase3, Recruiting